ConditionCancer

Sebaceous Gland Carcinoma

Sebaceous gland carcinoma is a rare, aggressive skin cancer that starts in the oil glands of the skin, most often in the eyelids. It usually appears in adults over 60 as a firm, painless, yellowish lump or a thickened eyelid, and it is easily mistaken for a chalazion (a common eyelid cyst) or chronic blepharitis. Delayed diagnosis is common. Treatment is surgical removal with careful margin checks. Some people have Muir-Torre syndrome, a form of Lynch syndrome that also raises the risk of bowel and other cancers.

Also called: Sebaceous carcinoma, meibomian gland carcinoma, sebaceous cell carcinoma, eyelid sebaceous carcinoma

At a glance

What it is
A cancer of the sebaceous (oil) glands, most often the meibomian glands of the eyelid.
Who gets it
Mostly adults over 60, more often women and people of Asian ancestry. Higher risk after radiation or with immune suppression.
Look-alikes
Chalazion, stye, blepharitis, conjunctivitis.
Diagnosis
Biopsy, often with map biopsies of the conjunctiva. Testing for Muir-Torre syndrome.
Treatment
Wide excision or Mohs surgery. Sometimes radiation, eye removal surgery for advanced disease.
Outlook
Good when caught early. Can spread to lymph nodes and beyond if diagnosis is delayed.

When to get help

See a doctor within a day or two

  • An eyelid lump that grows, bleeds, ulcerates or destroys eyelashes
  • A lump or swelling in front of the ear or in the neck in someone with an eyelid growth

Book a routine appointment

  • An eyelid "chalazion" that has not resolved after 1 to 2 months of warm compresses, or that keeps coming back in the same place
  • Chronic one-sided redness, thickening or crusting of an eyelid that does not respond to blepharitis treatment
  • Loss of eyelashes in one area of the lid
  • A yellowish, firm, painless bump on the face or scalp in someone over 60
  • A personal or family history of Lynch syndrome with a new skin bump

What sebaceous carcinoma is

Sebaceous glands make sebum, the oil that lubricates skin and hair. The eyelids contain specialized oil glands: the meibomian glands in the tarsal plates and the glands of Zeis at the lash line. Most sebaceous carcinomas arise in these eyelid glands, especially the upper lid, which has more meibomian glands. About a quarter of cases occur elsewhere: face, scalp, neck, trunk or genitals.

It accounts for a small percentage of eyelid cancers in Western countries, after basal cell carcinoma and squamous cell carcinoma, but a higher share in Asian populations.

Symptoms

  • A firm, painless, slowly growing lump in the eyelid, often yellowish
  • Thickening of the eyelid, sometimes involving the whole lid
  • Loss of eyelashes (madarosis) at the site
  • Chronic redness, irritation or crusting of one eyelid, mimicking blepharitis or conjunctivitis
  • A "chalazion" that keeps returning after treatment
  • Ulceration or bleeding in later stages

Outside the eye, it appears as a yellowish or pink nodule that may bleed or crust.

Why it is often missed

FeatureChalazionSebaceous carcinoma
AgeAny ageUsually over 60
CourseOften settles in weeks with warm compressesPersists or grows
RecurrenceUncommon in the same spotCommon after "drainage"
LashesNormalOften lost over the lesion
Lid marginNormalThickened, distorted or ulcerated
SidesEitherUsually one eye, persistent

Because chalazia are so common, ophthalmologists send tissue for pathology from recurrent or atypical "chalazia" in older adults. Unilateral, treatment-resistant blepharitis is another classic warning sign.

Risk factors

  • Age over 60
  • Female sex and Asian ancestry (eyelid tumors)
  • Previous radiation to the head and neck, for example for childhood retinoblastoma or acne treatment in the past
  • Weakened immune system, including organ transplant recipients and people with HIV
  • Muir-Torre syndrome: a variant of Lynch syndrome in which sebaceous skin tumors occur alongside colorectal, endometrial, urinary tract and other cancers. Sebaceous tumors outside the eyelid are particularly suggestive.

Diagnosis

  1. Examination of the eyelid with a slit lamp, flipping the lid to see the inner surface, and checking lymph nodes in front of the ear and in the neck.
  2. Biopsy: a full-thickness eyelid biopsy shows the cancer cells with fatty (lipid) contents. Special stains help distinguish it from basal or squamous cell carcinoma.
  3. Map biopsies of the conjunctiva, because this cancer can spread through the surface lining of the eye (pagetoid spread) beyond the visible lump.
  4. Staging: CT, MRI or PET scans for larger tumors or suspicious lymph nodes. Sentinel lymph node biopsy is sometimes used.
  5. Mismatch repair testing: the tumor is checked for the protein changes of Lynch syndrome. If abnormal, genetic counseling and germline testing follow, along with screening such as colonoscopy.

Treatment

  • Surgery: wide local excision with frozen-section or Mohs micrographic surgery to confirm clear margins. The eyelid is then reconstructed by an oculoplastic surgeon.
  • Cryotherapy or topical chemotherapy drops (such as mitomycin C) for spread across the conjunctiva.
  • Orbital exenteration (removal of the eye and surrounding tissues) for tumors that have invaded the eye socket.
  • Radiation therapy for people who cannot have surgery, after incomplete surgery, or for lymph node spread.
  • Lymph node surgery and systemic treatment, including immunotherapy in research or advanced settings, when cancer has spread.

Outlook

Small tumors diagnosed early and fully removed have an excellent outlook. The cancer can recur locally, spread to lymph nodes in up to about a fifth of eyelid cases, and occasionally spread to distant organs. Tumor size over 10 mm, involvement of both eyelids, long delays in diagnosis and spread to the conjunctiva worsen the outlook. Long-term follow-up with regular eyelid and lymph node checks is needed, and people with Muir-Torre syndrome need lifelong cancer screening.

Frequently asked questions

What does sebaceous carcinoma of the eyelid look like?

It typically looks like a firm, painless, yellowish lump or a thickened area in the eyelid, often with missing lashes. It can also look like a long-lasting red, irritated or crusted eyelid on one side, similar to blepharitis.

How can you tell sebaceous carcinoma from a chalazion?

A chalazion usually improves within weeks with warm compresses and rarely recurs in the same place. Sebaceous carcinoma persists, grows, recurs after drainage, and often causes lash loss. Only a biopsy can confirm it, which is why recurrent chalazia in older adults are biopsied.

Is sebaceous carcinoma deadly?

It can be if found late, because it can spread to lymph nodes and other organs. When diagnosed early and fully removed, the outlook is very good. Prompt biopsy of persistent eyelid lumps is key.

What is Muir-Torre syndrome?

Muir-Torre syndrome is a form of Lynch syndrome, an inherited condition caused by faulty DNA repair genes. People with it develop sebaceous skin tumors along with cancers of the colon, uterus, urinary tract and other organs. A sebaceous carcinoma diagnosis often prompts testing for it.

Who is at risk of sebaceous gland carcinoma?

Risk is higher in adults over 60, women, people of Asian ancestry, those who have had radiation to the head or face, people with weakened immune systems, and people with Lynch or Muir-Torre syndrome.

Sources

This guide was written from current patient and clinical guidance, including:

  • American Academy of Ophthalmology (EyeWiki): Sebaceous Carcinoma
  • National Cancer Institute: Skin Cancer Treatment, rare skin cancers
  • American Academy of Dermatology: Sebaceous carcinoma
  • National Comprehensive Cancer Network: Clinical practice guidelines, rare skin tumors
  • MedlinePlus Genetics: Lynch syndrome (Muir-Torre variant)